Development
CRISPR is used to shred the chromatin of p53-mutant cancer cells
Claim
The Innovative Genomics Institute used CRISPR-Cas12a2 to shred the chromatin of cancer cells carrying mutated p53, a flaw in nearly half of all cancers, while sparing healthy tissue.
Reported metric: ~50% of cancers
Reporting date: (not necessarily the event date)
Sources
Attribution and reporting linked by this record; links do not imply independent verification.
- Welcome to June 13, 2026 (theinnermostloop.substack.com)
Knowledge graphopen in browser →
Reported in
Cite or correct this record
Suggest a correction — opens a GitHub draft for you to review and submit.